Clinical Trials
27 trialsA Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer
Pfizer
PROTINCOL
Galician Research Group on Digestive Tumors
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Clearance Of Mucus In Stents (COMIS)
M.D. Anderson Cancer Center
EDOI
Gruppo Oncologico Italiano di Ricerca Clinica
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
Tranexamic Acid in Surgery of Advanced Ovarian Cancer
University Hospital, Linkoeping
NEOTHROCOVID
Centre Antoine Lacassagne
ENOXACARE
Les Laboratoires des Médicaments Stériles
FICT
Diagnostica Stago R&D
PREDICARE
LEO Pharma
Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology
Ohio State University Comprehensive Cancer Center
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Masonic Cancer Center, University of Minnesota
Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy
UNC Lineberger Comprehensive Cancer Center
COPPVATS
Aarhus University Hospital
MVTEP
University Hospital, Brest
Long-term Active Surveillance Study for Oral Contraceptives (LASS)
Center for Epidemiology and Health Research, Germany
Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer
CONKO-Studiengruppe
Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters
National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
National Cancer Institute (NCI)
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)
Italfarmaco
Heparin or Enoxaparin in Patients With Cancer
Northwestern University
Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery
National Cancer Institute (NCI)